Khoso Baluch, Director at Processa Pharmaceuticals, Inc. (PCSA), bought 2,269 shares at $2.54 ($6K) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Open-market purchase of $6k PCSA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CRMD | BUY | 2020-08-17 | $20K | — | Filing → |
| CRMD | BUY | 2020-03-18 | $9K | — | Filing → |
| CRMD | BUY | 2019-03-27 | $19K | — | Filing → |